SENSEX NIFTY

Religare Capital Markets

Nov 28, 2014 at 21:42 | Source: CNBC-TV18
In a bold new step for the Indian capital markets, the depository receipts scheme, 2014, permits listed and unlisted Indian companies and their security holders to issue new kinds of depository receipts.
Nov 28, 2014 at 19:39 | Source: PTI
Besides, market regulator SEBI has warned stock exchanges regarding probable inflow of funds from terror groups.
Nov 28, 2014 at 17:21 | Source: CNBC-TV18
The market ended the day at record highs on Friday following further fall in crude oil prices after the OPEC decided not to cut output.
Nov 28, 2014 at 15:41 | Source: CNBC-TV18
In an interview to CNBC-TV18, Gaurav Mehta, Vice-President, Institutional Equities at Ambit Capital, said he expects the market to continue to trade at 20x and sees a 12 percent earnings growth in FY15
Nov 28, 2014 at 12:42 | Source: CNBC-TV18
For 2015, the house would focus on midcaps as the big idea, said GautamTrivedi of Religare Capital Markets. They are very bullish on Ashiana Housing, Sanghi Industries and Ashok Leyland.
Nov 27, 2014 at 15:24 | Source: Moneycontrol.com
The key is to identify investments in segments of each asset category that may perform differently under different market conditions.
Nov 27, 2014 at 15:24 | Source: Moneycontrol.com
An ELSS is a diversified equity mutual fund which has a majority of the corpus invested in equities. Since it is an equity fund, returns from an ELSS fund reflect returns from the equity markets.
Nov 27, 2014 at 15:01 | Source: CNBC-TV18
"A 10 percent increase in tariff transmission leads to 20 percent improvement in bottomline for GSPL," Jal Irani, Sr VP - Wholesale Capital Markets, Edelweiss Financial Services.
Nov 27, 2014 at 09:20 | Source: Moneycontrol.com
According to Arihant Capital, in coming trading session if Nifty trades above 8500 level for first hour then it can test 8530 8580 levels. On the downside, below 8420 level the next support is at 8360 level.
Nov 27, 2014 at 08:43 | Source: CNBC
During the last year, the tech giant's stock price has soared more than 50 percent and on Tuesday the company's market capitalization reached a record USD 700 billion. But now the lingering question is how long can the momentum last?
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

253563 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th

cleverman

Platinum Member

92 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th

BSE/NSE Announcer

Platinum Member

5334 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th

Web Messenger

Platinum Member

253563 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

253563 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

253563 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

253563 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.